230 related articles for article (PubMed ID: 33678118)
1. TP53/miR-129/MDM2/4/TP53 feedback loop modulates cell proliferation and apoptosis in retinoblastoma.
Yao X; Shen H; Peng Q; Yu J
Cell Cycle; 2021; 20(5-6):603-615. PubMed ID: 33678118
[TBL] [Abstract][Full Text] [Related]
2. MDM2 but not MDM4 promotes retinoblastoma cell proliferation through p53-independent regulation of MYCN translation.
Qi DL; Cobrinik D
Oncogene; 2017 Mar; 36(13):1760-1769. PubMed ID: 27748758
[TBL] [Abstract][Full Text] [Related]
3. miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress.
Xiao J; Lin H; Luo X; Luo X; Wang Z
EMBO J; 2011 Feb; 30(3):524-32. PubMed ID: 21217645
[TBL] [Abstract][Full Text] [Related]
4. miR-29a sensitizes the response of glioma cells to temozolomide by modulating the P53/MDM2 feedback loop.
Chen Q; Wang W; Chen S; Chen X; Lin Y
Cell Mol Biol Lett; 2021 May; 26(1):21. PubMed ID: 34044759
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the p53 pathway in peripheral blood of retinoblastoma patients; potential biomarkers.
Martínez-Sánchez M; Moctezuma-Dávila M; Hernandez-Monge J; Rangel-Charqueño M; Olivares-Illana V
PLoS One; 2020; 15(6):e0234337. PubMed ID: 32502182
[TBL] [Abstract][Full Text] [Related]
6. miR-339-5p regulates the p53 tumor-suppressor pathway by targeting MDM2.
Jansson MD; Damas ND; Lees M; Jacobsen A; Lund AH
Oncogene; 2015 Apr; 34(15):1908-18. PubMed ID: 24882579
[TBL] [Abstract][Full Text] [Related]
7. Oncomir miR-125b suppresses p14(ARF) to modulate p53-dependent and p53-independent apoptosis in prostate cancer.
Amir S; Ma AH; Shi XB; Xue L; Kung HJ; Devere White RW
PLoS One; 2013; 8(4):e61064. PubMed ID: 23585871
[TBL] [Abstract][Full Text] [Related]
8. Dual inhibition of MDM2 and MDM4 in virus-positive Merkel cell carcinoma enhances the p53 response.
Park DE; Cheng J; Berrios C; Montero J; Cortés-Cros M; Ferretti S; Arora R; Tillgren ML; Gokhale PC; DeCaprio JA
Proc Natl Acad Sci U S A; 2019 Jan; 116(3):1027-1032. PubMed ID: 30598450
[TBL] [Abstract][Full Text] [Related]
9. Retinoblastoma protein modulates gankyrin-MDM2 in regulation of p53 stability and chemosensitivity in cancer cells.
Qiu W; Wu J; Walsh EM; Zhang Y; Chen CY; Fujita J; Xiao ZX
Oncogene; 2008 Jul; 27(29):4034-43. PubMed ID: 18332869
[TBL] [Abstract][Full Text] [Related]
10. miR-661 downregulates both Mdm2 and Mdm4 to activate p53.
Hoffman Y; Bublik DR; Pilpel Y; Oren M
Cell Death Differ; 2014 Feb; 21(2):302-9. PubMed ID: 24141721
[TBL] [Abstract][Full Text] [Related]
11. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
12. miR-605 joins p53 network to form a p53:miR-605:Mdm2 positive feedback loop in response to stress.
Xiao J; Lin H; Luo X; Luo X; Wang Z
EMBO J; 2011 Dec; 30(24):5021. PubMed ID: 22166998
[No Abstract] [Full Text] [Related]
13. LINC00657/miR-26a-5p/CKS2 ceRNA network promotes the growth of esophageal cancer cells via the MDM2/p53/Bcl2/Bax pathway.
Zhang XM; Wang J; Liu ZL; Liu H; Cheng YF; Wang T
Biosci Rep; 2020 Jun; 40(6):. PubMed ID: 32426838
[TBL] [Abstract][Full Text] [Related]
14. p53/mdm2 feedback loop sustains miR-221 expression and dictates the response to anticancer treatments in hepatocellular carcinoma.
Fornari F; Milazzo M; Galassi M; Callegari E; Veronese A; Miyaaki H; Sabbioni S; Mantovani V; Marasco E; Chieco P; Negrini M; Bolondi L; Gramantieri L
Mol Cancer Res; 2014 Feb; 12(2):203-16. PubMed ID: 24324033
[TBL] [Abstract][Full Text] [Related]
15. Mir-509-5p joins the Mdm2/p53 feedback loop and regulates cancer cell growth.
Ren ZJ; Nong XY; Lv YR; Sun HH; An PP; Wang F; Li X; Liu M; Tang H
Cell Death Dis; 2014 Aug; 5(8):e1387. PubMed ID: 25144722
[TBL] [Abstract][Full Text] [Related]
16. The oncoprotein HBXIP modulates the feedback loop of MDM2/p53 to enhance the growth of breast cancer.
Li H; Liu Q; Wang Z; Fang R; Shen Y; Cai X; Gao Y; Li Y; Zhang X; Ye L
J Biol Chem; 2015 Sep; 290(37):22649-61. PubMed ID: 26229107
[TBL] [Abstract][Full Text] [Related]
17. Augmented antitumor activity of 5-fluorouracil by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells.
Imanishi M; Yamamoto Y; Wang X; Sugaya A; Hirose M; Endo S; Natori Y; Yamato K; Hyodo I
Cancer Sci; 2019 Feb; 110(2):639-649. PubMed ID: 30488540
[TBL] [Abstract][Full Text] [Related]
18. E2F-1 transcriptional activity is a critical determinant of Mdm2 antagonist-induced apoptosis in human tumor cell lines.
Kitagawa M; Aonuma M; Lee SH; Fukutake S; McCormick F
Oncogene; 2008 Sep; 27(40):5303-14. PubMed ID: 18521084
[TBL] [Abstract][Full Text] [Related]
19. MDM2 and MDM4 Are Therapeutic Vulnerabilities in Malignant Rhabdoid Tumors.
Howard TP; Arnoff TE; Song MR; Giacomelli AO; Wang X; Hong AL; Dharia NV; Wang S; Vazquez F; Pham MT; Morgan AM; Wachter F; Bird GH; Kugener G; Oberlick EM; Rees MG; Tiv HL; Hwang JH; Walsh KH; Cook A; Krill-Burger JM; Tsherniak A; Gokhale PC; Park PJ; Stegmaier K; Walensky LD; Hahn WC; Roberts CWM
Cancer Res; 2019 May; 79(9):2404-2414. PubMed ID: 30755442
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cell-derived periostin functions as a tumor suppressor in gastric cancer through stabilizing p53 and E-cadherin proteins via the Rb/E2F1/p14ARF/Mdm2 signaling pathway.
Lv H; Liu R; Fu J; Yang Q; Shi J; Chen P; Ji M; Shi B; Hou P
Cell Cycle; 2014; 13(18):2962-74. PubMed ID: 25486483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
